My Portfolio Aug25

 Summary of August 2025

Portfolio @ End of Aug25

Even though KLCI soared 4% in Aug25, my portfolio only gained a little at 1.1%. 

Most stocks in my portfolio suffered loss in the month, but MI & TMCLife manage to register decent gain at 15% & 10% respectively.

There was no buy transaction in this month but I decided to dispose all my TAS shares. 

Perhaps I should have sold all my TAS shares much earlier but overall this investment still brings in 18% gain.

MI achieved a record high revenue of RM154.1mil in its FY25Q2 but its PATAMI dropped 11% QoQ to RM15.6mil (EPS 1.75sen).

The result will be much better if there was no RM16.8mil of forex loss in the quarter.

Meanwhile, the normally "pessimistic" management portrayed a rather positive vibe on its prospect for the second half of FY25. 

These might be the reasons its share price advanced for another 15% in Aug25

TMCLife's FY25Q4 result was not bad as it returned to profit after 2 quarters of consecutive losses.

Its revenue of RM93.3mil almost surpassed its record high but net profit was just RM2.4mil (EPS 0.14sen).

At the same time, TMCLife's largest shareholder Thomson Medical Group announced the launch of the RM18bil 26-acre Johor Bay project which include Thomson Hospital Iskandariah.

This hospital has a 500-bed capacity which can be expanded to 1,000.

The share price of TMCLife reacted a bit positively to this news but it will take at least until year 2030 for the new hospital to be ready.

KFIMA's FY26Q1 result was not that great. Its PATAMI dropped 21% YoY to RM22.4mil (EPS 8.14sen). 

There was a RM3.8mil of forex & impairment loss mainly in its food division.

Q1 is traditionally its weak quarter, hopefully its earning will improve in the rest of the quarters supported by new capacity in bulking division and CPO price above RM4000/MT.

JHM's FY25Q2 result was very bad. Despite the revenue increased 50% to RM74.6mil YoY mainly from its industrial segment, net loss widened to RM12.2mil.

The management blamed the loss to increased cost in preparation for new automotive projects and certain one-off adjustments.

The management foresees gradual recovery in the second half of 2025 contributed by mass production of the new projects.

The quarter results of FOCUSP, Hibiscus, MFCB are all OK. 

The bottom line of MFCB was unsurprising affected by Edenor due to gas supply shortage. Its management expects improvement in the performance of renewable energy, packaging & Edenor for the rest of the year.